Differentially Methylated Loci Distinguish Ovarian Carcinoma Histological Types: Evaluation of a DNA Methylation Assay in FFPE Tissue

by Kelemen, Linda E., Köbel, Martin, Chan, Angela, Taghaddos, Soreh, Dinu, Irina
Published 2013

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

by Milne, Katy, Alexander, Cheryl, Webb, John R, Sun, Winnie, Dillon, Kristy, Kalloger, Steve E, Gilks, C Blake, Clarke, Blaise, Köbel, Martin, Nelson, Brad H
Published 2012

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

by Milne, Katy, Köbel, Martin, Kalloger, Steven E., Barnes, Rebecca O., Gao, Dongxia, Gilks, C. Blake, Watson, Peter H., Nelson, Brad H.
Published 2013

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma

by Köbel, Martin, Piskorz, Anna M, Lee, Sandra, Lui, Shuhong, LePage, Cecile, Marass, Francesco, Rosenfeld, Nitzan, Mes Masson, Anne‐Marie, Brenton, James D
Published 2016

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

by Prentice, Leah M, Klausen, Christian, Kalloger, Steve, Köbel, Martin, McKinney, Steven, Santos, Jennifer L, Kenney, Challayne, Mehl, Erika, Gilks, C Blake, Leung, Peter, Swenerton, Ken, Huntsman, David G, Aparicio, Samuel AJ
Published 2007

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing

by Köbel, Martin, Rahimi, Kurosh, Rambau, Peter F., Naugler, Christopher, Le Page, Cécile, Meunier, Liliane, de Ladurantaye, Manon, Lee, Sandra, Leung, Samuel, Goode, Ellen L., Ramus, Susan J., Carlson, Joseph W., Li, Xiaodong, Ewanowich, Carol A., Kelemen, Linda E., Vanderhyden, Barbara, Provencher, Diane, Huntsman, David, Lee, Cheng-Han, Gilks, C. Blake, Mes Masson, Anne-Marie
Published 2016

Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium

by Kelemen, Linda E, Bandera, Elisa V, Terry, Kathryn L, Rossing, Mary Anne, Brinton, Louise A, Doherty, Jennifer A, Ness, Roberta B, Kjær, Susanne Krüger, Chang-Claude, Jenny, Köbel, Martin, Lurie, Galina, Thompson, Pamela J, Carney, Michael E, Moysich, Kirsten, Edwards, Robert, Bunker, Clare, Jensen, Allan, Høgdall, Estrid, Cramer, Daniel W, Vitonis, Allison F, Olson, Sara H, King, Melony, Chandran, Urmila, Lissowska, Jolanta, Garcia-Closas, Montserrat, Yang, Hannah, Webb, Penelope M, Schildkraut, Joellen M, Goodman, Marc T, Risch, Harvey A
Published 2013

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis

by Luchini, Claudio, Veronese, Nicola, Solmi, Marco, Cho, Hanbyoul, Kim, Jae-Hoon, Chou, Angela, Gill, Anthony J., Faraj, Sheila F., Chaux, Alcides, Netto, George J., Nakayama, Kentaro, Kyo, Satoru, Lee, Soo Young, Kim, Duck-Woo, Yousef, George M., Scorilas, Andreas, Nelson, Gregg S., Köbel, Martin, Kalloger, Steve E., Schaeffer, David F., Yan, Hai-Bo, Liu, Feng, Yokoyama, Yoshihito, Zhang, Xianyu, Pang, Da, Lichner, Zsuzsanna, Sergi, Giuseppe, Manzato, Enzo, Capelli, Paola, Wood, Laura D., Scarpa, Aldo, Correll, Christoph U.
Published 2015